BRET biosensors to study GPCR biology, pharmacology and signal transduction
Bioluminescence Resonance Energy Transfer (BRET) based biosensors have been extensively used over the last decade to study protein-protein interactions and intracellular signal transduction in living cells. In this review, we discuss the various BRET biosensors that have been developed to investigat...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2012-08-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00105/full |
| _version_ | 1811336155359084544 |
|---|---|
| author | Ali eSalahpour Stefano eEspinoza Bernard eMasri Vincent eLam Lawrence eBarak Raul R Gainetdinov |
| author_facet | Ali eSalahpour Stefano eEspinoza Bernard eMasri Vincent eLam Lawrence eBarak Raul R Gainetdinov |
| author_sort | Ali eSalahpour |
| collection | DOAJ |
| description | Bioluminescence Resonance Energy Transfer (BRET) based biosensors have been extensively used over the last decade to study protein-protein interactions and intracellular signal transduction in living cells. In this review, we discuss the various BRET biosensors that have been developed to investigate biology, pharmacology and signalling of G protein-coupled receptors (GPCRs). GPCRs form two distinct types of multiprotein signal transduction complexes based upon their inclusion of G proteins or β-arrestins that can be differentially affected by drugs that exhibit functional selectivity toward G protein or β-arrestin signalling. BRET has been especially adept at illuminating the dynamics of protein-protein interactions between receptors, G proteins, β-arrestins, and their many binding partners in living cells; as well as measuring the formation and accumulation of second messengers following receptor activation. Specifically, we discuss in detail the application of BRET to study dopamine and trace amine receptors signalling presenting examples of an EPAC biosensor to measure cAMP, β-arrestin biosensors to determine their recruitment to the receptor, and dopamine D2 receptor and Trace Amine Associated Receptor 1 (TAAR1) biosensors to investigate heterodimerization between them. As the biochemical spectrum of BRET biosensors expands, the number of signalling pathways that can be measured will concomitantly increase. This will be particularly useful for the evaluation of functional selectivity in which the real time BRET capability to measure distinct signalling modalities will dramatically shorten the time to characterize new generation of biased drugs. These emerging approaches will further expand the growing application of BRET in the screening for novel pharmacologically active compounds. |
| first_indexed | 2024-04-13T17:35:12Z |
| format | Article |
| id | doaj.art-835e2cd2754a49099d08f617bbc05fd5 |
| institution | Directory Open Access Journal |
| issn | 1664-2392 |
| language | English |
| last_indexed | 2024-04-13T17:35:12Z |
| publishDate | 2012-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj.art-835e2cd2754a49099d08f617bbc05fd52022-12-22T02:37:25ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922012-08-01310.3389/fendo.2012.0010530991BRET biosensors to study GPCR biology, pharmacology and signal transductionAli eSalahpour0Stefano eEspinoza1Bernard eMasri2Vincent eLam3Lawrence eBarak4Raul R Gainetdinov5University of TorontoItalian Institute of TechnologyINSERMUniversity of TorontoDuke UniversityItalian Institute of TechnologyBioluminescence Resonance Energy Transfer (BRET) based biosensors have been extensively used over the last decade to study protein-protein interactions and intracellular signal transduction in living cells. In this review, we discuss the various BRET biosensors that have been developed to investigate biology, pharmacology and signalling of G protein-coupled receptors (GPCRs). GPCRs form two distinct types of multiprotein signal transduction complexes based upon their inclusion of G proteins or β-arrestins that can be differentially affected by drugs that exhibit functional selectivity toward G protein or β-arrestin signalling. BRET has been especially adept at illuminating the dynamics of protein-protein interactions between receptors, G proteins, β-arrestins, and their many binding partners in living cells; as well as measuring the formation and accumulation of second messengers following receptor activation. Specifically, we discuss in detail the application of BRET to study dopamine and trace amine receptors signalling presenting examples of an EPAC biosensor to measure cAMP, β-arrestin biosensors to determine their recruitment to the receptor, and dopamine D2 receptor and Trace Amine Associated Receptor 1 (TAAR1) biosensors to investigate heterodimerization between them. As the biochemical spectrum of BRET biosensors expands, the number of signalling pathways that can be measured will concomitantly increase. This will be particularly useful for the evaluation of functional selectivity in which the real time BRET capability to measure distinct signalling modalities will dramatically shorten the time to characterize new generation of biased drugs. These emerging approaches will further expand the growing application of BRET in the screening for novel pharmacologically active compounds.http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00105/fullArrestinsGPCRsBRETcAMPGRKsScreening assay |
| spellingShingle | Ali eSalahpour Stefano eEspinoza Bernard eMasri Vincent eLam Lawrence eBarak Raul R Gainetdinov BRET biosensors to study GPCR biology, pharmacology and signal transduction Frontiers in Endocrinology Arrestins GPCRs BRET cAMP GRKs Screening assay |
| title | BRET biosensors to study GPCR biology, pharmacology and signal transduction |
| title_full | BRET biosensors to study GPCR biology, pharmacology and signal transduction |
| title_fullStr | BRET biosensors to study GPCR biology, pharmacology and signal transduction |
| title_full_unstemmed | BRET biosensors to study GPCR biology, pharmacology and signal transduction |
| title_short | BRET biosensors to study GPCR biology, pharmacology and signal transduction |
| title_sort | bret biosensors to study gpcr biology pharmacology and signal transduction |
| topic | Arrestins GPCRs BRET cAMP GRKs Screening assay |
| url | http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00105/full |
| work_keys_str_mv | AT aliesalahpour bretbiosensorstostudygpcrbiologypharmacologyandsignaltransduction AT stefanoeespinoza bretbiosensorstostudygpcrbiologypharmacologyandsignaltransduction AT bernardemasri bretbiosensorstostudygpcrbiologypharmacologyandsignaltransduction AT vincentelam bretbiosensorstostudygpcrbiologypharmacologyandsignaltransduction AT lawrenceebarak bretbiosensorstostudygpcrbiologypharmacologyandsignaltransduction AT raulrgainetdinov bretbiosensorstostudygpcrbiologypharmacologyandsignaltransduction |